Is hypertriglyceridemia a reliable indicator of cholesterol-depleted apoB particles?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted apoB particles?
Authors
Keywords
-
Journal
Journal of Clinical Lipidology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-05-12
DOI
10.1016/j.jacl.2023.05.093
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
- (2022) Emil Hagström et al. CIRCULATION
- Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis
- (2022) Anna Helgadottir et al. European Journal of Preventive Cardiology
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
- (2021) Camilla Ditlev Lindhardt Johannesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease
- (2021) Michael G. Levin et al. CIRCULATION
- Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk
- (2021) Allan D. Sniderman et al. JAMA Cardiology
- Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis
- (2021) Nicholas A. Marston et al. JAMA Cardiology
- Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
- (2020) Tom G. Richardson et al. PLOS MEDICINE
- Causes and Consequences of Hypertriglyceridemia
- (2020) Chris J. Packard et al. Frontiers in Endocrinology
- Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke
- (2020) Shuai Yuan et al. ANNALS OF NEUROLOGY
- Relationships between Smoking Status, Cardiovascular Risk Factors, and Lipoproteins in a Large Japanese Population
- (2020) Marie Nakamura et al. Journal of Atherosclerosis and Thrombosis
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Cholesteryl ester transfer protein and its inhibitors
- (2018) Sudichhya Shrestha et al. JOURNAL OF LIPID RESEARCH
- Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia: A randomized controlled trial
- (2017) Sally Chiu et al. PLoS One
- Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men
- (2010) Min-Jeong Shin et al. ATHEROSCLEROSIS
- Reversal of Small, Dense LDL Subclass Phenotype by Normalization of Adiposity
- (2009) Patty W. Siri-Tarino et al. Obesity
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started